Home
>
National Drug Code (NDC)
>
Methimazole
Methimazole - 0615-6500-39 - (Methimazole)
Drug Information of Methimazole
| Product NDC: | 0615-6500 |
| Proprietary Name: | Methimazole |
| Non Proprietary Name: | Methimazole |
| Active Ingredient(s): | 5 mg/1 & nbsp; Methimazole |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Methimazole
| Product NDC: | 0615-6500 |
| Labeler Name: | NCS HealthCare of KY, Inc dba Vangard Labs |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040411 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20010327 |
Package Information of Methimazole
| Package NDC: | 0615-6500-39 |
| Package Description: | 30 TABLET in 1 BLISTER PACK (0615-6500-39) |
NDC Information of Methimazole
| NDC Code | 0615-6500-39 |
| Proprietary Name | Methimazole |
| Package Description | 30 TABLET in 1 BLISTER PACK (0615-6500-39) |
| Product NDC | 0615-6500 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Methimazole |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20010327 |
| Marketing Category Name | ANDA |
| Labeler Name | NCS HealthCare of KY, Inc dba Vangard Labs |
| Substance Name | METHIMAZOLE |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Thyroid Hormone Synthesis Inhibitor [EPC],Thyroid Hormone Synthesis Inhibitors [MoA] |
